Matthew Campen, PhD, MSPH
UNM College of Pharmacy, Pharmaceutical Sciences
Cancer Control and Population Sciences
I am enthusiastic about participating on the Advisory Committee for the Cancer Research Training, Education and Career Enhancement core of the UNMCCC P30. As the director of our Clinical and Translational Science Center’s Career Development (KL2) program and also the mentoring director for a NIGMS-funded P20, I can provide a strong background to support the objectives of the UNMCCC. I have made a commitment to training at all levels, including undergraduate (4), graduate (17, with 5 as primary mentor), professional (7), postdoctoral (7), and junior faculty (6) mentees. I have established roles as a mentoring director for junior faculty-focused career development grants. Importantly, I am highly dedicated to supporting the education and career development of women and underrepresented minorities.
My own lab has been continuously funded since 2002, primarily through NIH funding, but also with support from the EPA, CDC, and numerous pharmaceutical sponsors for preclinical safety and efficacy studies. Currently I hold 3 R01 grants and a large 3-year supplement, on topics related to inhalation of metal contaminated dusts and complex gas-particle mixtures as cardiovascular toxins. My laboratory is broadly interested in mechanisms underlying the systemic vascular effects caused by inhaled toxicants. Recent studies examined the molecular and pathophysiological basis of epidemiologically-observed links between neurological outcomes, such as neurodegenerative and neurodevelopmental diseases and air pollution. This has generated knowledge related to fragmented and modified endogenous peptides, which have broader implications for target organ vascular effects. Importantly, my research extends from bench-level basic research to applications at both the community and clinical level; this translational breadth will benefit the present COBRE as we provide for the research and mentoring needs of a broad heterogeneous cohort of mentored principal investigators.